A patient testimonial stating a result is an effectiveness claim about the product that patient received, which for a compounded preparation is a claim with no review behind it, and a LegitScript reviewer reads a five-star widget the same way it reads the headline above it.
Analytics, advertising pixels, session recorders and chat widgets on pages where a patient describes a condition are a live regulatory issue independent of LegitScript, and a certification reviewer reading your site with developer tools open sees exactly the same tags an enforcement lawyer would.
Telehealth operators routinely offer NABP accreditation, a HIPAA attestation, a SOC 2 report or a state licence when an acquirer asks for LegitScript certification, and none of the four answers the question, because each was designed to satisfy a different party about a different risk.
A supplement sold in the same cart, the same bundle and the same brand voice as a prescription medicine tends to read as making a disease claim by association, which turns a low-risk product line into the part of a LegitScript application that needs explaining.
Nobody outside LegitScript decides an application or sets the pace of its review, so any provider offering a guaranteed approval or a promised decision date is describing authority they do not have, and that single test disqualifies more of this market than any other question.
Peptides are the category where a LegitScript reviewer asks a structural question before a marketing one, because the first thing to establish is what the substance is and on what basis a compounder may lawfully prepare it, and research-use framing on a consumer site answers neither.
An asynchronous telehealth model is workable where the states served permit it, but a LegitScript reviewer assesses whether a genuine prescribing decision happens, and the evidence for that is the intake logic, the contraindication screening and the rate at which prescribers actually decline.
Probationary Certification is a status LegitScript assigns rather than one a merchant applies for, it carries a higher annual fee and heavier monitoring, and because the public listing shows it, every counterparty who checks the listing can see which kind of certified you are.
A LegitScript certification attaches to a website rather than to a company, so a telehealth platform serving twenty clinics has to answer a question its architecture never asked: whether the patient transacts on the platform's domain or on the clinic's, because that decides who the applicant is.
Certification is issued by LegitScript per website rather than per company, so a brand with four domains files four applications, and the difference between a manageable programme and four separate ordeals is deciding which evidence is shared and which is genuinely per site.
Testosterone, menopause and thyroid brands are certified routinely, but the category combines compounded preparations, controlled substances in some formulations and outcome marketing aimed at ageing, which is why a LegitScript reviewer reads the optimisation language before anything else.
Clinical practice in the United States is licensed state by state, so a telehealth clinic has three separate coverage maps to reconcile, and the gap a LegitScript reviewer finds is almost always between where the marketing runs and where a prescriber or a pharmacy is actually permitted to operate.